Satralizumab Linker

Satralizumab Linker

Satralizumab Linker

Min.Order / FOB Price:Get Latest Price

0

Negotiable

  • Min.Order :0
  • Purity: 95%

Keywords

6,12,15,18,21,24,27,30,33-Nonaoxa-3,9-diazapentatriacontanamide, 2-(4-aminobutyl)-35-[4-[[[[4-[(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)methyl]cyclohexyl]carbonyl]amino]methyl]-1H-1,2,3-triazol-1-yl]... (2S)-2-(4-Aminobutyl)-35-[4-[[[[4-[(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)methyl]cyclohexyl]carbonyl]amino]methyl]-1H-1,2,3-triazol-1-yl]-N-[4-(hydroxymethyl)phenyl]-4,8-dioxo-6,12,15,18,21,24,27,3...

Quick Details

  • Appearance:
  • Application:For research use only.
  • PackAge:
  • ProductionCapacity:
  • Storage:
  • Transportation:

Superiority:

We provide customized and high-quality Satralizumab Linker product for your project.

Details:

Satralizumab Linker is a key compound utilized in the biomedical industry to develop targeted drug therapies. It plays a vital role in conjugating satralizumab, an antibody used for treating neuromyelitis optica spectrum disorder (NMOSD), with a specific

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View